The Role oF Monocyte to High Density Lipoprotein Ratio in Predicting Atrial High Rate Episodes Dedected by Cardiac Implantable Electronic Devices

INTRODUCTION[|]Technological advances have allowed cardiac implantable electronic devices (CIEDs) to detect, analyze, and store atrial high-rate episodes (AHREs), which are surrogate for the term silent atrial fibrillation (AF). The association of AHREs with adverse clinical events has been demonstr...

Full description

Bibliographic Details
Main Author: Seckin Satilmis
Format: Article
Language:English
Published: KARE Publishing 2018-06-01
Series:İstanbul Kuzey Klinikleri
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-35761
id doaj-169f1efabb144a25b8c2cfd6e43827d7
record_format Article
spelling doaj-169f1efabb144a25b8c2cfd6e43827d72021-01-24T18:35:16ZengKARE Publishingİstanbul Kuzey Klinikleri2148-49022018-06-01529610110.14744/nci.2017.35761NCI-35761The Role oF Monocyte to High Density Lipoprotein Ratio in Predicting Atrial High Rate Episodes Dedected by Cardiac Implantable Electronic DevicesSeckin Satilmis0Department of Cardiology, Acibadem Atakent University Hospital, Istanbul, TurkeyINTRODUCTION[|]Technological advances have allowed cardiac implantable electronic devices (CIEDs) to detect, analyze, and store atrial high-rate episodes (AHREs), which are surrogate for the term silent atrial fibrillation (AF). The association of AHREs with adverse clinical events has been demonstrated in several recent studies, implying that morbidity and mortality can be significantly prevented by prompt recognition and intervention. Inflammation and oxidative stress are among several mechanisms that contribute to the pathogenesis of AF. The monocyte-to-high-density lipoprotein ratio (M/H ratio) is a novel indicator of both inflammation and oxidative stress. In this study, we aimed to investigate the value of the M/H ratio for predicting AHREs detected by CIEDs.[¤]METHODS[|]A total of 203 patients (mean age: 57.5+9.1 years, 60.1% male) implanted with a dual pacemaker because of sick sinus syndrome were included. Blood samples were obtained from the patients after 12 h of fasting for the analysis of routine biochemistry tests and the lipid panel in the morning of device implantation. At a clinical visit 6 months after CIED implantation, the devices were interrogated to detect the occurrence of AHREs. AHREs were defined as atrial episodes faster than 220 bpm and lasting longer than 5 min. The patients were divided into two groups depending on the presence of AHREs during pacemaker interrogation: Group 1 (AHRE present) and Group 2 (AHRE absent).[¤]RESULTS[|]At the clinical visit 6 months after CIED implantation, 51 (25.1%) patients had at least one AHRE. The M/H ratio was significantly higher in patients in Group 1 (11.41+-1.24) than in those in Group 2 (8.17+-1.02) (p<0.01). On performing multivariate Cox regression analysis, the M/H ratio was found to be associated with the occurrence of AHREs in patients with CIEDs (OR: 22.813, 95% CI: 6.852–75.953, p<0.01).[¤]DISCUSSION AND CONCLUSION[|]The M/H ratio is an indicator of inflammation and oxidative stress, both of which play an important role in the pathogenesis of AF. This ratio was found to be statically higher in patients with AHREs detected by CIEDs than in those without AHREs.[¤]https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-35761atrial high-rate episodescardiac implantable electronic devices; monocyte-to-high-density lipoprotein ratio; inflammation; oxidative stress
collection DOAJ
language English
format Article
sources DOAJ
author Seckin Satilmis
spellingShingle Seckin Satilmis
The Role oF Monocyte to High Density Lipoprotein Ratio in Predicting Atrial High Rate Episodes Dedected by Cardiac Implantable Electronic Devices
İstanbul Kuzey Klinikleri
atrial high-rate episodes
cardiac implantable electronic devices; monocyte-to-high-density lipoprotein ratio; inflammation; oxidative stress
author_facet Seckin Satilmis
author_sort Seckin Satilmis
title The Role oF Monocyte to High Density Lipoprotein Ratio in Predicting Atrial High Rate Episodes Dedected by Cardiac Implantable Electronic Devices
title_short The Role oF Monocyte to High Density Lipoprotein Ratio in Predicting Atrial High Rate Episodes Dedected by Cardiac Implantable Electronic Devices
title_full The Role oF Monocyte to High Density Lipoprotein Ratio in Predicting Atrial High Rate Episodes Dedected by Cardiac Implantable Electronic Devices
title_fullStr The Role oF Monocyte to High Density Lipoprotein Ratio in Predicting Atrial High Rate Episodes Dedected by Cardiac Implantable Electronic Devices
title_full_unstemmed The Role oF Monocyte to High Density Lipoprotein Ratio in Predicting Atrial High Rate Episodes Dedected by Cardiac Implantable Electronic Devices
title_sort role of monocyte to high density lipoprotein ratio in predicting atrial high rate episodes dedected by cardiac implantable electronic devices
publisher KARE Publishing
series İstanbul Kuzey Klinikleri
issn 2148-4902
publishDate 2018-06-01
description INTRODUCTION[|]Technological advances have allowed cardiac implantable electronic devices (CIEDs) to detect, analyze, and store atrial high-rate episodes (AHREs), which are surrogate for the term silent atrial fibrillation (AF). The association of AHREs with adverse clinical events has been demonstrated in several recent studies, implying that morbidity and mortality can be significantly prevented by prompt recognition and intervention. Inflammation and oxidative stress are among several mechanisms that contribute to the pathogenesis of AF. The monocyte-to-high-density lipoprotein ratio (M/H ratio) is a novel indicator of both inflammation and oxidative stress. In this study, we aimed to investigate the value of the M/H ratio for predicting AHREs detected by CIEDs.[¤]METHODS[|]A total of 203 patients (mean age: 57.5+9.1 years, 60.1% male) implanted with a dual pacemaker because of sick sinus syndrome were included. Blood samples were obtained from the patients after 12 h of fasting for the analysis of routine biochemistry tests and the lipid panel in the morning of device implantation. At a clinical visit 6 months after CIED implantation, the devices were interrogated to detect the occurrence of AHREs. AHREs were defined as atrial episodes faster than 220 bpm and lasting longer than 5 min. The patients were divided into two groups depending on the presence of AHREs during pacemaker interrogation: Group 1 (AHRE present) and Group 2 (AHRE absent).[¤]RESULTS[|]At the clinical visit 6 months after CIED implantation, 51 (25.1%) patients had at least one AHRE. The M/H ratio was significantly higher in patients in Group 1 (11.41+-1.24) than in those in Group 2 (8.17+-1.02) (p<0.01). On performing multivariate Cox regression analysis, the M/H ratio was found to be associated with the occurrence of AHREs in patients with CIEDs (OR: 22.813, 95% CI: 6.852–75.953, p<0.01).[¤]DISCUSSION AND CONCLUSION[|]The M/H ratio is an indicator of inflammation and oxidative stress, both of which play an important role in the pathogenesis of AF. This ratio was found to be statically higher in patients with AHREs detected by CIEDs than in those without AHREs.[¤]
topic atrial high-rate episodes
cardiac implantable electronic devices; monocyte-to-high-density lipoprotein ratio; inflammation; oxidative stress
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-35761
work_keys_str_mv AT seckinsatilmis theroleofmonocytetohighdensitylipoproteinratioinpredictingatrialhighrateepisodesdedectedbycardiacimplantableelectronicdevices
AT seckinsatilmis roleofmonocytetohighdensitylipoproteinratioinpredictingatrialhighrateepisodesdedectedbycardiacimplantableelectronicdevices
_version_ 1724324878537981952